Complimentary content
The Mark Five: Policy Off Leash series continues with the third and fourth editions.
In the third edition, Mark Cushing, JD, shares critical information about how the FDA views telemedicine. The discussion focuses on off-label prescriptions and traditional VCPR in the FDA regulations.
The FDA rule is limited to extra-label drug prescriptions and was waived during Covid-19.”
In the fourth edition, Cushing shares how Ontario became a living laboratory for us down here in the states to learn from. They have successfully implemented telemedicine now for two and a half years and used it extensively during the Covid-19 pandemic.
Source: FDA Status on Animal Telemedicine, Mark Five: Policy Off Leash #3. Link.
Source: The Ontario Experience, Mark Five: Policy Off Leash #4. Link.